A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ML / Mycobacterium leprae

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ML  (>> Co-occurring Abbreviation)
Long Form:   Mycobacterium leprae
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Myelination key factor krox-20 is downregulated in Schwann cells and murine sciatic nerves infected by Mycobacterium leprae. SCs
2019 Tuberculosis and leprosy associated with historical human population movements in Europe and beyond - an overview based on mycobacterial ancient DNA. aDNA, Mtb
2018 Analysis of CTLA-4+49A/G gene polymorphism in cases with leprosy of Azerbaijan, Northwest Iran. T-ARMS-PCR
2016 Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis. IL, SCs, TNF
2016 Mycobacterium leprae-induced Insulin-like Growth Factor I attenuates antimicrobial mechanisms, promoting bacterial survival in macrophages. IGF-I, SOCS3
2015 Immunology of leprosy and diagnostic challenges. ---
2014 Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells. PNS, pSLCs
2014 Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment. BT, CHO, LL, SREBP
2013 Reprogramming diminishes retention of Mycobacterium leprae in Schwann cells and elevates bacterial transfer property to fibroblasts. pSLC
10  2013 Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients. HAART, PBMCs, RR
11  2013 Transforming growth factor-beta1 may be a key mediator of the fibrogenic properties of neural cells in leprosy. alpha-SMA, SCs, TGF-beta1
12  2012 CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages. ---
13  2012 [Phagocytosis of Mycobacterium leprae down-regulates anti-microbial activity of murine macrophages against Mycobacterium intracellulare]. LL
14  2011 Circulating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy. ENL, HC, IGF-I, NR BT, RR, TNF-alpha
15  2011 Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. SCs
16  2010 Involvement of 9-O-Acetyl GD3 ganglioside in Mycobacterium leprae infection of Schwann cells. SCs
17  2006 DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect? DCs
18  2004 Comparison between C57Bl/6 and C57Bl/10 mycobacterial mouse pleurisy with respect to cellular migration and nitric oxide production. BCG, L-NIO
19  2004 Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents. ---
20  1998 Experimental leprosy in rhesus monkeys: transmission, susceptibility, clinical and immunological findings. HIV, PGL-I, RM, SIV
21  1995 Experimental leprosy in monkeys. I. Sooty mangabey monkeys: transmission, susceptibility, clinical and pathological findings. IV/IC, MIs, SMM
22  1995 Experimental leprosy in monkeys. II. Longitudinal serological observations in sooty mangabey monkeys. ---
23  1995 Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition. ---
24  1994 [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings]. CMI
25  1985 Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients. LDC
26  1982 Ultrastructural characteristics of Mycobacterium bovis BCG and Mycobacterium leprae. CW, FF, UTS
27  1981 Antigen-specific suppressor cells in subclinical leprosy infection. ---